Ten-Day versus 14-Day Levofloxacin-Containing Triple Therapy for Second-Line Anti-Helicobacter pylori Eradication in Taiwan

Table 1

Demographic data and endoscopic appearances of the two patient groups.

	EAL-10 (𝑛=100)	EAL-14 (𝑛=100)
Characteristics
Age (year) (mean ± SD)	55.6±13.2	57.6±12.8
Gender (male/female)	44/56	45/55
Smoking	9 (9%)	6 (6%)
Alcohol consumption	8 (8%)	13 (13%)
Previous history of peptic ulcer	21 (21%)	29 (29%)
Endoscopic findings
Gastric ulcer	36 (36%)	35 (35%)
Duodenal ulcer	18 (18%)	20 (20%)
Gastric and duodenal ulcer	11 (11%)	14 (14%)
Unspecified (include gastritis)	35 (35%)	31 (31%)